Where Study Activation Time Actually Goes, and Why Your Timeline Doesn’t Show It
Activation is reported end to end, which can hide the waiting between stages. What 308 site activations show, and how to find your own handoff gaps.
One Amendment, Six Weeks Gone: A Study Startup Saga
Pre-activation protocol amendments quietly add weeks to trial activation. The fix is not heroics. It is treating startup as its own discipline, with three capabilities: shared readiness, shared language, and a shared clock.
How Specialized Study Startup Tools Work Alongside OnCore, Medidata, and Veeva
Study startup tools don’t replace OnCore, Medidata Rave, Veeva CTMS, or WCG eResearch. They cover the pre-activation phase and hand off cleanly at site activation. This post shows how a dedicated startup tool fits alongside your existing CTMS — with no integration required to get started.
When Study Startup Becomes a Bottleneck (And What to Do About It)
Study startup works fine at one or two studies. Then you add a third, a fourth, a fifth — and the coordination model that kept everything on track collapses. Here’s how to recognize the bottleneck and what to do about it.
Why Your CTMS Isn’t Built for Study Startup
Your CTMS tracks patient screening and enrollment, patient visits, financial milestones – all post-activation. But study startup – regulatory prep, contracts, budgets, feasibility – runs on spreadsheets and email. That gap costs sites weeks per study. Here’s why, and what purpose-built startup tools do differently.
Why Site IRB Submissions Fail the First Time: 7 Fixable Mistakes That Add Weeks to Your Timeline
⚡ Quick Answer IRB review times vary widely across institutions – and revision cycles can add weeks to your timeline. FDA’s FY 2023 inspections consistently cite the same issues: failure to follow the investigational plan, inadequate records, informed consent problems, and safety reporting delays. Common ICF errors include missing signatures, outdated form versions, and failure […]
The Unspoken Tradeoffs Sites Make to Hit Startup Timelines
Research sites make hidden compromises to meet sponsor timelines. Learn the 5 most common startup tradeoffs, which ones create downstream risk, and how PIs can make informed decisions.
What Breaks First When Sites Run Multiple Studies in Parallel
Study startup performance collapses at Study #3 due to the Coordination Tax. Learn the 5 warning signs, which operations break first, and a 90-day fix that cut activation time by 46%.
Benchmarking Study Startup — Internal vs External
How to Know If Your Timelines Are Good, or Just Normalized Delays — Learn to Benchmark Your Study Startup Performance Against Internal Trends, Industry Averages, and Efficiency Standards So You Know Where You Really Stand
The Minimal Viable Study Startup Dashboard – Only 6 Metrics You Need
Stop tracking 20 metrics across 5 spreadsheets. Here’s what actually predicts study startup delays and how to fix them before anyone asks.